1. Aetiology, pathogenesis of the disease and the amyloid beta hypothesis 2. Neuroinflammation in Alzheimer's disease 3. Recent updates in Chemistry of Alzheimer's: Synthetic molecules 4. Blood brain barrier and its significance in drug delivery to brain in AD 5. Nose to brain delivery for the treatment of Alzheimer's disease 6. Amyloid cascade, tau hypotheses and the role of oxidative stress in AD 7. Newer Biologicals and Biomaterials in therapy of Alzheimer's disease 8. Cationic nanoformulation in targeting Alzheimer's disease 9. Role of nanomedicine in the diagnosis of Alzheimer's disease 10. Design and development of nanotechnology-based delivery with CRISPR for Alzheimer's disease 11. Liposome as carrier for drug delivery in Alzheimer's disease 12. PLGA mediated Drug delivery for Alzheimer's disease 13. Regulatory, and ethical concerns use of nanomaterials 14. Symptoms and conventional treatment of Alzheimer's Disease 15. Dendrimers for the treatment of Alzheimer's disease 16. Precision medicines for the treatment of Alzheimer's disease 17. Nanoformulations Targeting Alzheimer's Disease 18. Lipid nanoparticles in targeting Alzheimer's 19. Novel Formulation approaches for Targeting Alzheimer's Disease 20. Micro and nanoemulsion as drug carriers in Alzheimer's 21. Targeted nanotechnology-based formulations 22. Challenges in nanotechnology-based drug delivery for Alzheimer's Disease 23. Current Trends and updates in the Treatment of Alzheimer's Disease 24. Pharmacokinetics and Pharmacodynamics of various novel formulations Targeting Alzheimer's Disease 25. Microbubble-based drug delivery for Alzheimer's drugs 26. Neurotoxicity, with the use of nanomaterials 27. Combinatorial therapy in AD